نتایج جستجو برای: methadone treatment

تعداد نتایج: 1396603  

Journal: :Science & Practice Perspectives 2005

Journal: :The International journal on drug policy 2018
Matthias Pierce Tim Millar J Roy Robertson Sheila M Bird

BACKGROUND The first evidence that the hazard ratio (HR) for methadone-specific death rises more steeply with age-group than for all drug-related deaths (DRDs) came from Scotland's cohort of 33,000 methadone-prescription clients. We aim to examine, for England, whether illicit opioid users' risk of methadone-specific death increases with age; and to pool age-related HRs for methadone-specific d...

Journal: :The journal of pain : official journal of the American Pain Society 2014
Roger Chou Ricardo A Cruciani David A Fiellin Peggy Compton John T Farrar Mark C Haigney Charles Inturrisi John R Knight Shirley Otis-Green Steven M Marcus Davendra Mehta Marjorie C Meyer Russell Portenoy Seddon Savage Eric Strain Sharon Walsh Lonnie Zeltzer

UNLABELLED Methadone is used for the treatment of opioid addiction and for treatment of chronic pain. The safety of methadone has been called into question by data indicating a large increase in the number of methadone-associated overdose deaths in recent years that has occurred in parallel with a dramatic rise in the use of methadone for chronic pain. The American Pain Society and the College ...

Journal: :Palliative medicine 2012
Olav Magnus S Fredheim Kristin Moksnes Petter C Borchgrevink Svetlana Skurtveit

BACKGROUND Opioid switching to methadone is reported frequently to improve pain control in patients with an unacceptable balance between pain control and side effects during treatment with first line opioids, but carries a risk of drug accumulation and respiratory depression. To justify this risk it is required that less risky treatments are tried beforehand and that a sufficiently large propor...

Journal: :Addiction 2007
Suzanne Nielsen Paul Dietze Nicole Lee Adrian Dunlop David Taylor

AIMS To examine concurrent buprenorphine and benzodiazepine consumption and to compare opioid toxicity symptoms induced by methadone and buprenorphine, examining factors associated with the reporting of these symptoms. DESIGN Self-report cross-sectional survey. SETTING Five needle syringe programmes and five opioid substitution treatment services in Melbourne, Australia. PARTICIPANTS A to...

Journal: :PLoS Medicine 2006
Jodie A Trafton Jared Minkel Keith Humphreys

BACKGROUND Randomized clinical trials of methadone maintenance have found that on average high daily doses are more effective for reducing heroin use, and clinical practice guidelines recommend 60 mg/d as a minimum dosage. Nevertheless, many clinicians report that some patients can be stably maintained on lower methadone dosages to optimal effect, and clinic dosing practices vary substantially....

Journal: :Journal of substance abuse treatment 2014
Robert P Schwartz Pierre K Alexandre Sharon M Kelly Kevin E O'Grady Jan Gryczynski Jerome H Jaffe

A benefit-cost analysis was conducted as part of a clinical trial in which newly-admitted methadone patients were randomly assigned to interim methadone (IM; methadone without counseling) for the first 4 months of 12 months of methadone treatment or 12 months of methadone with one of two counseling conditions. Health, residential drug treatment, criminal justice costs, and income data in 2010 d...

2014
Lois A Jackson Jane A Buxton Julie Dingwell Margaret Dykeman Jacqueline Gahagan Karen Gallant Jeff Karabanow Susan Kirkland Dolores LeVangie Ingrid Sketris Michael Gossop Carolyn Davison

BACKGROUND For over 50 years, methadone has been prescribed to opioid-dependent individuals as a pharmacological approach for alleviating the symptoms of opioid withdrawal. However, individuals prescribed methadone sometimes require additional interventions (e.g., counseling) to further improve their health. This study undertook a realist synthesis of evaluations of interventions aimed at impro...

Journal: :Journal of psychoactive drugs 2009
Heather Schacht Reisinger Robert P Schwartz Shannon Gwin Mitchell James A Peterson Sharon M Kelly Kevin E O'Grady Erica A Marrari Barry S Brown Michael H Agar

Longer retention in drug abuse treatment is associated with better patient outcomes, and research indicates the first 12 months of methadone treatment are critical to patient success. Nevertheless, large-scale multisite longitudinal studies over the past three decades indicate that the majority of patients drop out during the first year of methadone treatment. Through an examination of 42 quali...

Journal: :Clinical pharmacokinetics 2002
Chin B Eap Thierry Buclin Pierre Baumann

Methadone is widely used for the treatment of opioid dependence. Although in most countries the drug is administered as a racemic mixture of (R)- and (S)- methadone, (R)-methadone accounts for most, if not all, of the opioid effects. Methadone can be detected in the blood 15-45 minutes after oral administration, with peak plasma concentration at 2.5-4 hours. Methadone has a mean bioavailability...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید